secwatch.observer — SEC 8-K summary
======================================

Issuer:     THC Therapeutics, Inc. (—)
CIK:        0001404935
Form:       8-K
Filed at:   2026-10-30T21:26:43+00:00
Accession:  0001477932-26-006561
Event type: m_and_a
Sentiment:  negative
Materiality: 0.60
Item codes: 1.02, 5.03, 9.01
LLM model:  deepseek-v4.1-flash:cloud@v2

THC Therapeutics terminates ST Holdings share exchange deal, citing accounting difficulty
--------------------------------------------------------------------------------

- Share Exchange Agreement with ST Holdings Group, LLC and its subsidiaries, signed June 20, 2025, was terminated by mutual agreement on October 30, 2026.
- Company cited difficulty accounting for the transaction; the parties are still discussing a possible future acquisition of some or all ST Holdings assets.
- On July 7, 2026 the company filed a Nevada Amended and Restated Certificate of Designation creating 500,000 Series D Convertible Preferred shares.
- Each Series D share carries 10 votes, converts into common at $0.01 per share, and participates with common stock in any declared dividends.
- Filing signed by Scott Cox, Interim Chief Executive Officer, and dated October 30, 2026.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1404935/000147793226006561/0001477932-26-006561-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1404935/000147793226006561/thct_8k.htm
  HTML page:      https://secwatch.observer/filing/0001477932-26-006561

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer